Results 311 to 320 of about 1,465,858 (395)

Management strategies for preventing and recovering from zoysiagrass winterkill

Crop, Forage &Turfgrass Management, Volume 11, Issue 2, December 2025.
Abstract Zoysiagrass (Zoysia spp. Willd.) is a warm‐season grass used from tropical to temperate climates, and it generally requires fewer inputs than most other cool‐ and warm‐season turfgrasses. The development of new zoysiagrass cultivars has increased its use in the United States, but its adaptation and specific uses are species and cultivar ...
T. Q. Carr, W. J. Hutchens, A. J. Patton, R. C. Braun, D. McFadden, M. D. Richardson   +5 more
wiley   +1 more source

Reply to Gücer, F.; Dünnebacke, J. Comment on "Hawez et al. Endometrial Intraepithelial Neoplasia, Concurrent Endometrial Cancer and Risk for Pelvic Sentinel Node Metastases. <i>Cancers</i> 2024, <i>16</i>, 4215". [PDF]

Cancers (Basel)
Hawez T, Bollino M, Lönnerfors C, Persson J.   +3 more
europepmc   +1 more source

Utilising Drones in Agriculture: A Review on Remote Sensors, Image Processing and Their Application

Modern Agriculture, Volume 3, Issue 2, December 2025.
The utilisation of drones in agriculture involves the integration of advanced sensing technologies, data analytics and targeted applications. Drones equipped with sensors such as RGB, multispectral and hyperspectral capture diverse spatial and spectral data.
Chetan Yumnam, Andyco B. Marak, Manish Kumar, Sanjay Khatri, Shravan Kumar, Sapna Soni, K. Kabil, V. Balaji, Ramesh K. Sahni, Satya Prakash Kumar, V. P. Chaudhary   +10 more
wiley   +1 more source

Sentinel Node Biopsy in Melanoma Remains a Valuable Clinical Tool. Comment on Dixon et al. Primary Cutaneous Melanoma-Management in 2024. J. Clin. Med. 2024, 13, 1607. [PDF]

J Clin Med
Pennington TE, Thompson JF.
europepmc   +1 more source

Twenty‐year survival outcomes after multipeptide vaccination for resected high‐risk melanoma: A post‐hoc analysis of a randomized clinical trial

International Journal of Cancer, Volume 157, Issue 9, Page 1912-1923, 1 November 2025.
What's new? While melanoma vaccines have shown therapeutic promise, predicting their clinical benefits is challenged by factors such as delayed response to immunotherapy and scarcity of biomarkers. Here, the authors examined the long‐term efficacy of vaccination with either 4 or 12 class I MHC‐restricted peptides in high‐risk melanoma.
Emily K. Ninmer, Hong Zhu, Kimberly A. Chianese‐Bullock, Craig L. Slingluff Jr.   +3 more
wiley   +1 more source

The Role of Multiparametric MRI Radiomics for Preoperative Prediction of Axillary Lymph Node Metastasis in Patients With Invasive Breast Cancer: A Comparative Study

Cancer Innovation, Volume 4, Issue 5, October 2025.
This study compared the preoperative noninvasive prediction of axillary lymph node metastasis in patients with invasive breast cancer using radiomics derived from single and multi‐sequence MRI. The combined radiomics model outperformed the single‐sequence models, with the DCE model performing better among the single‐sequence models.
Qingcong Kong, Yongxin Chen, Yi Sui, Siyi Chen, Xinghan Lv, Wenjie Tang, Zhidan Zhong, Xiaomeng Yu, Kuiming Jiang, Lei Zhang, Jianning Chen, Jie Qin, Yuan Guo   +12 more
wiley   +1 more source

Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability. [PDF]

Int J Clin Oncol
Yamashita T, Itoh T, Asano T, Suina A, Nishimori M, Munakata S, Satoh H.   +6 more
europepmc   +1 more source

Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double‐blind, randomized controlled DHA‐WIN trial

International Journal of Cancer, Volume 157, Issue 7, Page 1405-1419, 1 October 2025.
What's New? Omega‐3 docosahexaenoic acid (DHA) has shown pleiotropic anti‐cancer effects both in vitro and in animal models. However, clinical evidence of DHA efficacy is limited. This randomized, double‐blind, placebo‐controlled trial tested the efficacy of supplementation with DHA 4.4 g/day during 18 weeks of breast cancer neoadjuvant chemotherapy ...
Jaqueline Munhoz, Marnie Newell, Gilbert Bigras, Susan Goruk, Anil Abraham Joy, Sunita Ghosh, Kerry S. Courneya, Vera Mazurak, Claire M. Douglas, Xiaofu Zhu, Bohdarianna Zorniak, John Mackey, Judith Meza Junco, Julie Price Hiller, Karen King, Sanraj K. Basi, Catherine J. Field   +16 more
wiley   +1 more source

ASO Author Reflections: Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas. [PDF]

Ann Surg Oncol
Winder AA, Spillane AJ, Smith AL.
europepmc   +1 more source